Dr. Robert d. Marsh
Claim this profileNorthShore University HealthSystem-Evanston Hospital
Studies Colorectal Cancer
Studies Gastric Cancer
7 reported clinical trials
31 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
Stage III
dMMR negative
2Gastric Cancer
Stage III
Affiliated Hospitals
Clinical Trials Robert d. Marsh is currently running
Chemotherapy + Bevacizumab + Atezolizumab
for Colorectal Cancer
This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab may stop or slow colorectal cancer by blocking the growth of new blood vessels necessary for tumor growth. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.
Recruiting2 awards Phase 31 criteria
Duloxetine
for Colorectal Cancer
This phase II/III trial studies the best dose of duloxetine and how well it works in preventing pain, tingling, and numbness (peripheral neuropathy) caused by treatment with oxaliplatin in patients with stage II-III colorectal cancer. Duloxetine increases the amount of certain chemicals in the brain that help relieve depression and pain. Giving duloxetine in patients undergoing treatment with oxaliplatin for colorectal cancer may help prevent peripheral neuropathy.
Recruiting0 awards Phase 2 & 33 criteria
More about Robert d. Marsh
Clinical Trial Related4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Robert d. Marsh has experience with
- Fluorouracil
- Oxaliplatin
- Leucovorin Calcium
- Irinotecan Hydrochloride
- Bevacizumab
- Atezolizumab
Breakdown of trials Robert d. Marsh has run
Colorectal Cancer
Esophageal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robert d. Marsh specialize in?
Robert d. Marsh focuses on Colorectal Cancer and Gastric Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Robert d. Marsh currently recruiting for clinical trials?
Yes, Robert d. Marsh is currently recruiting for 3 clinical trials in Evanston Illinois. If you're interested in participating, you should apply.
Are there any treatments that Robert d. Marsh has studied deeply?
Yes, Robert d. Marsh has studied treatments such as Fluorouracil, Oxaliplatin, Leucovorin Calcium.
What is the best way to schedule an appointment with Robert d. Marsh?
Apply for one of the trials that Robert d. Marsh is conducting.
What is the office address of Robert d. Marsh?
The office of Robert d. Marsh is located at: NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois 60201 United States. This is the address for their practice at the NorthShore University HealthSystem-Evanston Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.